Llobet, D, Mojal, S, Vallve, C, Carrasco, M, Vilalta, N, Mateo, J, Moret, C, Millón, J, Soria, JM, Souto, JC. The von Willebrand factor/ADAMTS13 ratio as an indicator of venous thromboembolism risk: results from the RETROVE project. JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2026; 59(1)DOI:10.1007/s11239-025-03165-4. PMID:40813530. IF:2.200(Q2/5D).

Real, J, Franch-Nadal, J, Mauricio, D, Vlacho, B, Carrasco, M, Monroy, G, Hernández, M. IMPACT OF RAMADAN ON OVERDIAGNOSIS OF GESTATIONAL DIABETES: MATCHED CASE-CONTROL ANALYSIS BASED ON CLINICAL REGISTRIES. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).

Ward J, Le NQ, Suryakant S, Brody JA, Amouyel P, Boland A, Bown R, Cullen B, Debette S, Deleuze JF, Emmerich J, Graham N, Germain M, Anderson JJ, Pell JP, Lyall DM, Lyall LM, Smith DJ, Wiggins KL, Soria JM, Souto JC, Morange PE, Smith NL, Trégouët DA, Sabater-Lleal M, Strawbridge RJ. Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism.. Blood Advances. 2023; 7(18)DOI:10.1182/bloodadvances.2023010562. PMID:37399490. IF:7.400(Q1/2D).

Jayaraman, S, Choi, K, Pérez, A, Miñambres, I, Sánchez-Quesada, JL, Gursky, O. Binding of human low-density lipoproteins to type-I collagen is synergistic with the pro-atherogenic lipoprotein remodeling. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2026; 1872(3)DOI:10.1016/j.bbadis.2025.168142. PMID:41419069. IF:4.200(Q1/2D).